The firm's financial position appears vulnerable, supported by a limited $9.8 million cash buffer that must sustain operations against a P/B ratio of 0.05.
| Metric | Sep'24 | Sep'23 | Sep'22 | Sep'21 | Sep'20 | Sep'19 | Sep'18 | Sep'17 |
|---|
| Total Current Assets | 29.77M | 34.51M | 30.03M | 40.37M | 37.52M | 24.97M | 22.17M | 21.96M |
| Cash & Short-Term Investments | 18.14M | 22.42M | 14.32M | 10.47M | 11.87M | 4.59M | 5.28M | 5.37M |
| Cash Only | 9.82M | 7.48M | 14.32M | 10.47M | 11.87M | 4.59M | 5.26M | 5.37M |
| Short-Term Investments | 8.32M | 14.94M | 0 | 0 | 0 | 0 | 14.58K | 0 |
| Accounts Receivable | 5.77M | 6.35M | 4.87M | 13.47M | 12.62M | 6.14M | 5.29M | 1.01M |
| Days Sales Outstanding | 83.98 | 49.91 | 27.42 | 86.1 | 92.1 | 48.62 | 38.36 | 16.33 |
| Inventory | 5.05M | 4.99M | 8.88M | 12.5M | 11.99M | 12.52M | 9.59M | 12.85M |
| Days Inventory Outstanding | 87.84 | 40.74 | 55.28 | 88.63 | 103.03 | 125.52 | 82.84 | 244.95 |
| Other Current Assets | 0 | 0 | 659.78K | 2.14M | 384.85K | 351.92K | 363.99K | 944K |
| Total Non-Current Assets | 23.23M | 16.75M | 34.49M | 34.99M | 10.63M | 10.3M | 11.17M | 11.43M |
| Property, Plant & Equipment | 14.91M | 12.71M | 12.29M | 11.48M | 7.66M | 7.67M | 8.49M | 8.84M |
| Fixed Asset Turnover | 1.68x | 3.66x | 5.28x | 4.97x | 6.53x | 6.01x | 5.93x | 2.55x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.54M | 3.42M | 1.73M | 1.93M | 1.88M | 1.83M | 1.96M | 2.07M |
| Long-Term Investments | 3.36M | 606K | 20.09M | 20.96M | 540.52K | 539.68K | 407.35K | 163.03K |
| Other Non-Current Assets | 0 | 0 | 172.91K | 188.91K | 179.32K | 0 | 0 | 0 |
| Total Assets | 53M | 51.26M | 64.53M | 75.35M | 48.14M | 35.27M | 33.34M | 33.38M |
| Asset Turnover | 0.47x | 0.91x | 1.01x | 0.76x | 1.04x | 1.31x | 1.51x | 0.68x |
| Asset Growth % | 3.41% | -20.56% | -14.37% | 56.52% | 36.51% | 5.79% | -0.13% | - |
| Total Current Liabilities | 8.78M | 6.66M | 9.18M | 18.17M | 18.42M | 11.66M | 14.29M | 17.97M |
| Accounts Payable | 4.13M | 3.59M | 5.29M | 6.64M | 4.38M | 3.57M | 3.76M | 4.69M |
| Days Payables Outstanding | 71.76 | 29.32 | 32.93 | 47.12 | 37.6 | 35.78 | 32.47 | 89.29 |
| Short-Term Debt | 0 | 479.71K | 1.67M | 7.87M | 7.35M | 4.9M | 4.22M | 6.94M |
| Deferred Revenue (Current) | 568.5K | 1.11M | 677.96K | 2.84M | 3.93M | 2.31M | 4.63M | 5.05M |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 3.39x | 5.18x | 3.27x | 2.22x | 2.04x | 2.14x | 1.55x | 1.22x |
| Quick Ratio | 2.82x | 4.43x | 2.30x | 1.53x | 1.39x | 1.07x | 0.88x | 0.51x |
| Cash Conversion Cycle | 100.06 | 61.33 | 49.77 | 127.61 | 157.52 | 138.35 | 88.73 | 171.99 |
| Total Non-Current Liabilities | 134.39K | 246.45K | 382.48K | 509.93K | 877.86K | 972.34K | 1.33M | 1.76M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 24.57K | 72.54K | 106.18K | 155.72K | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 8.91M | 6.91M | 9.56M | 18.68M | 19.3M | 12.63M | 15.62M | 19.73M |
| Total Debt | 0 | 577.85K | 1.77M | 8.03M | 7.59M | 4.9M | 4.22M | 6.94M |
| Net Debt | -9.82M | -6.9M | -12.55M | -2.44M | -4.28M | 308.69K | -1.04M | 1.58M |
| Debt / Equity | - | 0.01x | 0.03x | 0.14x | 0.26x | 0.22x | 0.24x | 0.51x |
| Debt / EBITDA | - | - | 0.53x | 2.24x | 1.27x | 0.67x | 0.58x | 2.93x |
| Net Debt / EBITDA | -14.58x | - | -3.77x | -0.68x | -0.72x | 0.04x | -0.14x | 0.66x |
| Interest Coverage | -0.88x | - | - | 41.41x | 19.81x | 27.63x | 27.62x | 4.00x |
| Total Equity | 44.09M | 44.35M | 54.96M | 56.67M | 28.84M | 22.64M | 17.72M | 13.66M |
| Equity Growth % | -0.58% | -19.31% | -3.01% | 96.48% | 27.4% | 27.74% | 29.76% | - |
| Book Value per Share | 6.10 | 6.14 | 7.61 | 8.31 | 4.12 | 3.23 | 2.53 | 1.95 |
| Total Shareholders' Equity | 42.74M | 42.79M | 53.05M | 54.86M | 26.1M | 19.89M | 15.32M | 11.24M |
| Common Stock | 59.58K | 59.58K | 59.58K | 59.58K | 50K | 50K | 50K | 50K |
| Retained Earnings | 4.35M | 5.9M | 15.51M | 14.69M | 12.2M | 7.56M | 2.87M | 3.06M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 1.92M | 425.25K | 1.07M | 3.71M | 1.6M | 30.64K | 150.36K | 440.33K |
| Minority Interest | 1.35M | 1.56M | 1.91M | 1.81M | 2.74M | 2.74M | 2.4M | 2.41M |
Liquidity and Solvency Risk
As reported in recent financial disclosures, BGM's balance sheet trajectory appears increasingly precarious, with the firm's inability to sustain positive operating margins suggesting that its limited capital base is being eroded by ongoing operational losses and a significant 45.99% year-over-year decline in top-line revenue growth.
The lack of available balance sheet data prevents a granular assessment of asset quality, yet the persistent negative operating margins imply that the firm's net worth is likely under sustained pressure. Investors should monitor whether the company's capital structure can withstand further revenue volatility without requiring dilutive financing or asset liquidation.
Based on the company's reported figures, BGM maintains a $9.8 million cash position, which serves as the primary liquidity buffer against its current operational burn, though this reserve appears insufficient to support long-term strategic pivots or significant supply chain disruptions in the volatile Chinese agricultural market.
The reliance on a relatively small cash reserve to cover fixed administrative costs suggests a narrow margin for error. If the firm's working capital requirements for licorice root procurement increase, the current liquidity position may prove inadequate to sustain operations without external capital injection.
According to recent regulatory filings, the company's reliance on biological assets and agricultural inventories introduces significant valuation uncertainty, as the shelf life and potency of its licorice and heparin products may necessitate future impairments that are not currently reflected in the firm's headline financial position.
The circular production model, while operationally efficient, complicates the valuation of inventory and by-products, potentially masking underlying liquidity constraints. Analysts should remain cautious regarding the potential for non-cash charges to further weaken the balance sheet if inventory turnover continues to decelerate alongside the broader revenue contraction.
Quick answers to the most common questions about buying BGM stock.
As of 2024, BGM Group Ltd. (BGM) had total assets of $53.0M including $29.8M in current assets.
BGM Group Ltd. (BGM) carries total debt of $0.0M, offset by $18.1M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
BGM Group Ltd. (BGM) has total shareholders' equity (book value) of $42.7M ($6.10 book value per share). Book value represents the net worth of the company belonging to common stock holders.
BGM Group Ltd. (BGM) reported a current ratio of 3.39x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.